Only one study (ERSPC) reported a 21% significant reduction of prostate cancer-specific mortality in a pre-specified subgroup of men aged 55 to 69 years.
只有一个研究(ERSPC)记录了在预先指定、55至69岁男性的次群组中，摄护腺癌死亡率有21%的显著降低。
youdao
应用推荐
模块上移
模块下移
不移动